In light of former President Biden's prostate cancer diagnosis, retired North Carolina journalist Jim Ware details his own journey.

Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust ...

Following former President Joe Biden's diagnosis with metastatic prostate cancer, news coverage has focused on his lack of ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Here’s what you should know about PSA screening, why medical guidelines vary and why individualized approaches are essential ...

The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

The idea that a man could receive regular exams and still wind up with a late-stage discovery? It doesn’t surprise me at all.

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, ...